Study concept and design: A. Rewers, M. Rewers.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: A. Rewers, M. Rewers.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Dong.
Obtained funding: A. Rewers, M. Rewers.
Administrative, technical, or material support: A. Rewers, M. Rewers.
Study supervision: A. Rewers, Slover, Klingensmith, M. Rewers.
Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr A. Rewers reported receiving personal fees from the Diabetes Technology Society and Roche Diagnostics International. Dr Klingensmith reported serving on a safety monitoring board for Novo Nordisk. No other disclosures were reported.
Funding/Support: This study was supported by grant P30 DK57156 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and by funding from the Children’s Diabetes Foundation in Denver.
Role of the Funder/Sponsor: The NIDDK and the Children’s Diabetes Foundation in Denver had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.